Matthew Christopher

4.2k total citations · 1 hit paper
24 papers, 2.2k citations indexed

About

Matthew Christopher is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Matthew Christopher has authored 24 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Matthew Christopher's work include Hematopoietic Stem Cell Transplantation (8 papers), Chemokine receptors and signaling (6 papers) and Immune Response and Inflammation (6 papers). Matthew Christopher is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Chemokine receptors and signaling (6 papers) and Immune Response and Inflammation (6 papers). Matthew Christopher collaborates with scholars based in United States, Japan and Australia. Matthew Christopher's co-authors include Daniel C. Link, Laura G. Schuettpelz, Takashi Nagasawa, Joshua N. Borgerding, Adam Greenbaum, Ryan B. Day, Yen‐Michael S. Hsu, Fulu Liu, Jill Woloszynek and Mahil Rao and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Matthew Christopher

24 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance

2013 1.0k citations Adam Greenbaum, Yen‐Michael S. Hsu et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Christopher United States	11	1.2k	957	583	549	537	24	2.2k
Bianca Nowlan Australia	17	936 0.8×	774 0.8×	520 0.9×	362 0.7×	382 0.7×	32	1.9k
Osman Yılmaz United States	9	1.6k 1.3×	929 1.0×	791 1.4×	597 1.1×	457 0.9×	17	2.5k
Kathryn Weibrecht United States	8	1.4k 1.2×	805 0.8×	990 1.7×	875 1.6×	766 1.4×	8	3.0k
Ryan B. Day United States	9	704 0.6×	480 0.5×	448 0.8×	406 0.7×	390 0.7×	16	1.4k
Damien Reynaud United States	15	1.3k 1.1×	1.2k 1.2×	1.3k 2.2×	493 0.9×	491 0.9×	27	3.0k
Liliana Habler Israel	8	854 0.7×	874 0.9×	532 0.9×	438 0.8×	871 1.6×	9	2.0k
Scott T. Avecilla United States	14	911 0.8×	321 0.3×	515 0.9×	383 0.7×	390 0.7×	36	1.6k
Abel Sánchez‐Aguilera Spain	21	564 0.5×	485 0.5×	1.0k 1.7×	564 1.0×	646 1.2×	31	2.2k
G Dewald United States	23	942 0.8×	759 0.8×	836 1.4×	702 1.3×	351 0.7×	41	2.3k
Lina Thorén Sweden	9	1.1k 0.9×	937 1.0×	1.0k 1.8×	339 0.6×	249 0.5×	10	2.3k

Countries citing papers authored by Matthew Christopher

Since Specialization

Citations

This map shows the geographic impact of Matthew Christopher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Christopher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Christopher more than expected).

Fields of papers citing papers by Matthew Christopher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Christopher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Christopher. The network helps show where Matthew Christopher may publish in the future.

Co-authorship network of co-authors of Matthew Christopher

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Christopher. A scholar is included among the top collaborators of Matthew Christopher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Christopher. Matthew Christopher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abboud, Ramzi, Mark A. Schroeder, Michael P. Rettig, et al.. (2024). Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation. Blood. 145(13). 1382–1394. 1 indexed citations

Swarnkar, Gaurav, Prashant Gupta, Timothy E. Peterson, et al.. (2024). IĸBζ as a Central Modulator of Inflammatory Arthritis Pathogenesis. Arthritis & Rheumatology. 77(2). 124–139. 1 indexed citations

Jacoby, Meagan A., John S. Welch, Peter Westervelt, et al.. (2023). Abstract 4342: Predictive precision medicine platform accurately predicts individual patient response to AML treatments to maximize outcomes. Cancer Research. 83(7_Supplement). 4342–4342. 2 indexed citations

Abboud, Ramzi, Feng Gao, Michael P. Rettig, et al.. (2022). A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(3). S298–S299. 1 indexed citations

Chendamarai, Ezhilarasi, Michael P. Rettig, Reyka G. Jayasinghe, et al.. (2022). Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells. Blood. 141(14). 1718–1723. 21 indexed citations

Christopher, Matthew, Margery Gang, Andrew J. Menssen, et al.. (2021). Tumor suppressor function of <I>WT1</I> in acute promyelocytic leukemia. Haematologica. 107(1). 342–346. 6 indexed citations

Christopher, Matthew, et al.. (2021). Biology of Disease Relapse in Myeloid Disease: Implication for Strategies to Prevent and Treat Disease Relapse After Stem-Cell Transplantation. Journal of Clinical Oncology. 39(5). 386–396. 7 indexed citations

Methot, Joey L., Matthew Christopher, Hua Zhou, et al.. (2020). Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors. ACS Medicinal Chemistry Letters. 11(12). 2461–2469. 11 indexed citations

Ruprecht, Benjamin, Julie Di Bernardo, Zhao Wang, et al.. (2020). A mass spectrometry-based proteome map of drug action in lung cancer cell lines. Nature Chemical Biology. 16(10). 1111–1119. 34 indexed citations

10.

McGowan, Meredeth A., Matthew Christopher, Xavier Fradera, et al.. (2019). Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(1). 126715–126715. 11 indexed citations

11.

Fradera, Xavier, Joey L. Methot, Matthew Christopher, et al.. (2019). Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow. Bioorganic & Medicinal Chemistry Letters. 29(18). 2575–2580. 15 indexed citations

12.

Greenbaum, Adam, Yen‐Michael S. Hsu, Ryan B. Day, et al.. (2013). CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature. 495(7440). 227–230. 1026 indexed citations breakdown →

13.

Borgerding, Joshua N., Priya Gopalan, Matthew Christopher, Daniel C. Link, & Laura G. Schuettpelz. (2012). G-CSF Treatment Induces Hematopoietic Stem Cell Quiescence but Loss of Repopulating Activity. Blood. 120(21). 1206–1206. 1 indexed citations

14.

Christopher, Matthew, Mahil Rao, Fulu Liu, Jill Woloszynek, & Daniel C. Link. (2011). Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. The Journal of Experimental Medicine. 208(2). 251–260. 243 indexed citations

15.

Christopher, Matthew, Fulu Liu, Matthew J. Hilton, Fanxin Long, & Daniel C. Link. (2009). Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood. 114(7). 1331–1339. 172 indexed citations

16.

Rao, Mahil, Matthew Christopher, Jill Woloszynek, Fulu Liu, & Daniel C. Link. (2009). Expression of the G-CSF Receptor in Monocytes Is Sufficient to Mediate Osteoblast Suppression and HSPC Mobilization by G-CSF in Mice.. Blood. 114(22). 563–563. 3 indexed citations

17.

Christopher, Matthew & Daniel C. Link. (2008). Granulocyte Colony-Stimulating Factor Induces Osteoblast Apoptosis and Inhibits Osteoblast Differentiation. Journal of Bone and Mineral Research. 23(11). 1765–1774. 97 indexed citations

18.

Christopher, Matthew & Daniel C. Link. (2007). Regulation of neutrophil homeostasis. Current Opinion in Hematology. 14(1). 3–8. 153 indexed citations

19.

Christopher, Matthew, Priya Gopalan, & Daniel C. Link. (2006). G-CSF Disrupts the Stem Cell Niche by Increasing Turnover of Bone Marrow Osteoblasts.. Blood. 108(11). 87–87. 2 indexed citations

20.

Christopher, Matthew, et al.. (2004). Disruption of SDF-1/CXCR4 Signaling during Flt-3 Ligand and Stem Cell Factor (SCF) Induced Hematopoietic Progenitor Mobilization.. Blood. 104(11). 4139–4139. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact